Enrico Longato

Prevalence and impact of diabetes among people infected with SARS-CoV-2

Gian Paolo Fadini, Mario Luca Morieri, Enrico Longato et al. · Journal of Endocrinological Investigation · 2020 · 559 citations · Full text

Medicine, Infectious Diseases, Preventive Medicine +10

Exposure to dipeptidyl‐peptidase‐4 inhibitors and <scp>COVID</scp> ‐19 among people with type 2 diabetes: A case‐control study

Gian Paolo Fadini, Mario Luca Morieri, Enrico Longato et al. · Diabetes Obesity and Metabolism · 2020 · 99 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +8

Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life

Enrico Longato, Barbara Di Camillo, Giovanni Sparacino et al. · BMJ Open Diabetes Research & Care · 2020 · 83 citations · Full text

Medicine, Endocrinology, Pharmacology +17

A Deep Learning Approach to Predict Diabetes’ Cardiovascular Complications From Administrative Claims

Enrico Longato, Gian Paolo Fadini, Giovanni Sparacino et al. · IEEE Journal of Biomedical and Health Informatics · 2021 · 71 citations

Computing, Biomedical Informatics, Health Informatics +17

Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice

Enrico Longato, Barbara Di Camillo, Giovanni Sparacino et al. · Cardiovascular Diabetology · 2020 · 68 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16